Literature DB >> 2538180

Influence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar artery.

H E Connor1, W Feniuk.   

Abstract

1. We have investigated the influence of endothelial damage on the cerebrovascular reactivity to 5-hydroxytryptamine (5-HT) and some selective 5-HT agonists in canine basilar artery. 2. 5-HT, alpha-methyl 5-HT, GR 43175 (3-[2-dimethyl amino] ethyl-N-methyl-1H-indole-5-methane sulphonamide) and 5-carboxamidotryptamine (5-CT) produced concentration-dependent contractions of untreated dog basilar artery with a functional endothelium. Following endothelial damage by perfusion with Triton X-100 (0.1%), which abolished the relaxant response to substance P, the maximum contractile effect of 5-HT, alpha-methyl 5-HT, GR 43175 and 5-CT was markedly enhanced although there was little change in the EC50 values. Endothelial damage did not modify the vasoconstrictor effect of the thromboxane agonist, U46619, or potassium chloride. 3. Neither 5-HT nor 5-CT caused relaxation of untreated canine basilar arteries contracted with prostaglandin F2 alpha, U46619, uridine triphosphate or potassium chloride. 4. These results suggest that canine basilar artery spontaneously releases endothelium-derived relaxing factor which can attenuate the vasoconstrictor effect of 5-HT and selective 5-HT agonists. This effect appeared to be specific since the vasoconstrictor response to U46619 was not modified. 5. These results demonstrate that the cerebrovascular endothelium can markedly influence the reactivity of the vascular smooth muscle of canine basilar artery to 5-HT and 5-HT1-like receptor agonists. However we could find no evidence that 5-HT receptor activation stimulates endothelial cell function as it does in some other blood vessels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538180      PMCID: PMC1854303          DOI: 10.1111/j.1476-5381.1989.tb11797.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Involvement of endothelium in the relaxation of isolated chick jugular vein by 5-hydroxytryptamine.

Authors:  Y Imaizumi; M Baba; Y Imaizumi; M Watanabe
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

2.  Identification of a serotonin type 2 receptor linked to prostacyclin synthesis in vascular smooth muscle cells.

Authors:  S R Coughlin; M A Moskowitz; L Levine
Journal:  Biochem Pharmacol       Date:  1984-02-15       Impact factor: 5.858

Review 3.  Role of endothelium in responses of vascular smooth muscle.

Authors:  R F Furchgott
Journal:  Circ Res       Date:  1983-11       Impact factor: 17.367

4.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

Authors:  B P Richardson; G Engel; P Donatsch; P A Stadler
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

5.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

6.  Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.

Authors:  E Müller-Schweinitzer; G Engel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

7.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.

Authors:  T M Cocks; J A Angus
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

8.  Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.

Authors:  E Apperley; P P Humphrey; G P Levy
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

9.  GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.

Authors:  P P Humphrey; W Feniuk; M J Perren; H E Connor; A W Oxford; L H Coates; D Butina
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

10.  Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery.

Authors:  P B Bradley; P P Humphrey; R H Williams
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

View more
  16 in total

1.  Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.

Authors:  S J MacLennan; G R Martin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries.

Authors:  M Urabe; H Kawasaki; K Takasaki
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

3.  Conditions permitting suppression of stretch-induced and vasoconstrictor tone by basal nitric oxide activity in porcine cerebral artery.

Authors:  S J Wallis; W Martin
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  The vasomotor effects of 5-hydroxytryptamine on equine basilar arteries in vitro.

Authors:  A Miyamoto; T Obi; A Nishio
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

5.  Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep.

Authors:  S E Webber; R O Salonen; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

6.  ATP release mechanisms of endothelial cell-mediated stimulus-dependent hyperalgesia.

Authors:  Elizabeth K Joseph; Paul G Green; Jon D Levine
Journal:  J Pain       Date:  2014-05-02       Impact factor: 5.820

7.  The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation.

Authors:  P D Macintyre; B Bhargava; K J Hogg; J D Gemmill; W S Hillis
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

8.  Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation.

Authors:  C M Stubbs; G J Waldron; H E Connor; W Feniuk
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

9.  Endothelium-dependent contractile responses to 5-hydroxytryptamine in the rabbit basilar artery.

Authors:  J M Seager; A H Clark; C J Garland
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

10.  Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.

Authors:  V Deckert; D Pruneau; J L Elghozi
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.